A gentler catheter may cut infection risk for women in hospitals

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Adult female subjects ≥ 18 years of age at the time of signing the informed consent. 2. Requiring treatment with indwelling urinary catheters or PureWick™ Flex Female External Catheter (PureWick™ FFEC) for urinary management, including urinary incontinence for at least 3 days after enrollment. 3. Has limited mobility and is not able to use sanitary devices that facilitate controlled bladder emptying like bedpans, commode chairs, voiding at the toilet 4. The expected length of stay from enrollment to hospital discharge is at minimum 10 days 5. Willing to comply with all study procedures in this protocol 6. The subject must be willing and able to read, understand, sign, and date the informed consent form. Exclusion Criteria: 1. Clinically confirmed urinary retention. 2. Requiring precise urine output measurement 3. Is known to be pregnant at time of enrollment 4. Has a confirmed diagnosis of a urinary tract infection (UTI), catheter-associated urinary tract infection (CAUTI), or sepsis at the time of the planned indwelling urinary catheter implantation 5. Has documented colonization or infection with multidrug-resistant organisms (MDROs) at the time of the planned indwelling urinary catheter implantation 6. Is agitated, combative, and/or uncooperative and may remove the catheter 7. Has any pre-existing neurological, psychiatric, or other conditions that would confound quality of life assessment or would make it difficult to self-report on quality-of-life questionnaires in the opinion of the investigator 8. Has any other condition that, in the opinion of the investigator, would preclude them from participating in the study. Additional Exclusion Criteria (Cohort 2 only - PureWick™ FFEC): 9. Has frequent episodes of bowel incontinence without a fecal management system in place 10. Has moderate to heavy menstruation and cannot use a tampon or menstrual cup 11. Has vaginal or other chronic non-urinary tract infections (UTIs), active genital herpes 12. Has any clinically relevant skin condition (e.g. wound, lesion or irritation) affecting the genital, perineal, or sacral area that could interfere with safe and effective device use where is in contact with the device.